Compositions and methods for nucleic acid modifications
AssigneeAcrigen Biosciences
InventorsDavid Rabuka, Allison Sharrar, Michael Schelle, Luisa Mayumi Arake de Tacca
Life of this patent
Estimating the term…
Abstract
The present disclosure provides nucleases and compositions, methods, and systems thereof for nucleic acid modification. More particularly, the present disclosure provides compositions and system comprising a nuclease comprising an amino acid sequence having at least 70% identity to any of SEQ ID NOs: 1-1096 and at least one gRNA.
Claims86
An engineered nuclease comprising an amino acid sequence having at least 70% identity, at least 80% identity, at least 90% identity, at least 95% identity or at least 99% identity to any of SEQ ID NOs:
- 1-5, 8-465, 1063-1070, 1080-1081 and 1095.
A composition comprising:
- a nuclease, wherein the nuclease comprises a sequence with at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99 or greater than 99 identity to any one of SEQ ID NOs:
- 1-1096, or a nucleic acid comprising a sequence encoding the nuclease.
A system for modifying a first target nucleic acid comprising:
- a) a nuclease comprising an amino acid sequence having 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, greater than 99% or 100% identity to any of SEQ ID NOs:
- 1-1096 or a first nucleic acid sequence encoding the nuclease;
- and
- b) an engineered guide RNA (gRNA) comprising a first region configured to interact with the nuclease and a second region configured to hybridize with a portion of the first target nucleic acid or a second nucleic acid sequence encoding the gRNA.
A method of generating a cell that expresses a recombinant receptor comprising introducing into the cell:
- a nuclease comprising an amino acid sequence having at least 70% identity, at least 80% c identity, at least 90% identity, at least 95% identity or at least 99% identity to any of SEQ ID NOs:
- 1-1096 or a nucleic acid molecule comprising a sequence encoding the nuclease;
- at least one guide RNA (gRNA) complementary to at least a portion of a target nucleic acid or a nucleic acid comprising a sequence encoding the at least one gRNA;
- and
- a nucleic acid encoding the recombinant receptor.
A method modifying a target nucleic acid in a plant comprising providing to the plant, or a plant cell, seed, fruit, plant part, or propagation material of the plant:
- a nuclease comprising an amino acid sequence having at least 70% identity, at least 80% identity, at least 90% identity, at least 95% identity or at least 99% identity to any of SEQ ID NOs:
- 1-1096 or a nucleic acid molecule comprising a sequence encoding the nuclease;
- and
- at least one guide RNA (gRNA) complementary to at least a portion of the target nucleic acid or a nucleic acid comprising a sequence encoding the at least one gRNA.
A method for treating a disease or disorder in a subject comprising administering to the subject in need thereof:
- a cell comprising a recombinant receptor or a nucleic acid encoding the recombinant receptor, the nuclease, or a nucleic acid encoding thereof, and at least one gRNA, or a nucleic acid encoding thereof;
- or
- a nuclease comprising an amino acid sequence having at least 70% identity, at least 80% identity, at least 90% identity, at least 95% identity or at least 99% identity to any of SEQ ID NOs:
- 1-1096 or a nucleic acid molecule comprising a sequence encoding the nuclease;
- and
- at least one guide RNA (gRNA) complementary to at least a portion of a target nucleic acid or a nucleic acid comprising a sequence encoding the at least one gRNA.
Dependencies are inferred from the claim text.